Contracts › 75N91025F00001
75N91025F00001: Manufacture of Clinical Grade Epstein-Barr Virus Vaccine
Awarded to Mriglobal by National Institutes of Health (NIH).
$3.5Mobligated
$3.5Mpotential value
21 September 2027current end date
See modifications, all subcontractors and funding in FedSift →
| Contract | 75N91025F00001 |
|---|---|
| Vehicle | 75N91023D00010 |
| Awardee | Mriglobal |
| Awarding agency | National Institutes of Health (NIH) |
| Awarding office | NIH NCI |
| NAICS | 541690 Other Scientific and Technical Consulting Services |
| PSC | Q301 Reference Laboratory Testing |
| Place of performance | MO |
| Period of performance | 22 September 2025 to 21 September 2027 |
| Potential end | 21 September 2027 |
| Estimated recompete solicitation | ~Q1 2027 (estimate, ~6 months before expiry) |
Source: USASpending.gov (FPDS), public federal procurement data, as the agency reported it. Our record updated 03 October 2026. The solicitation date is an estimate from the end date, not a posted date.
Other expiring 541690 contracts · All expiring contracts · USASpending record